STAT3 and cancer: By utilizing BBB permeable, small-molecule STAT3-inhibitor (STAT3i, SH-4-54), we found that low dose (100 nM) effectively abrogated nicotine-induced neutrophils polarization by decreasing activated STAT3 expression without any effect on cancer cells.